Astera Labs, Inc. — Director's Dealing 2024

Dec 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-12-04

Reporting Person: ALBA MANUEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-04	Common Stock	S	3000	$116.69	Disposed	456863	Indirect
2024-12-04	Common Stock	S	2000	$115.5302	Disposed	2070498	Indirect
2024-12-04	Common Stock	S	1100	$116.751	Disposed	2069398	Indirect
2024-12-04	Common Stock	S	2100	$118.0359	Disposed	2067298	Indirect
2024-12-04	Common Stock	S	1300	$119.2981	Disposed	2065998	Indirect
2024-12-04	Common Stock	S	1400	$119.9336	Disposed	2064598	Indirect
2024-12-04	Common Stock	S	100	$121.05	Disposed	2064498	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Indirect

Footnotes

F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024.

F2: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.1300 to $116.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.4100 to $117.1700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.6200 to $118.6100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.6600 to $119.6200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.6800 to $120.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.